ページ内を移動するためのリンクです。

Financial Highlights

*Notice Regarding Change in Fiscal Year
Due to a change in the fiscal year end to December, FY2014, a transitional period for the change, covers nine months from April 1, 2014 to December 31, 2014.
Thus, percentage changes compared to the previous fiscal year (twelve-month period) are not applicable.

Key Results (Tables)Click to view graphs.

Consolidated Financial Data (JPY billion / % change)

  FY2010 FY2011 FY2012 FY2013 FY2014*
Net Sales 1,127.6 1,154.6 1,218.1 1,452.8 1,224.3
4.0% 2.4% 5.5% 19.3%
Operating Income 126.3 148.7 169.7 198.7 196.5
28.2% 17.7% 14.1% 17.1%
Ordinary Income 128.4 152.1 184.5 215.2 217.2
17.7% 18.5% 21.3% 16.7%
Net Income 82.4 92.2 122.4 151.0 143.1
22.1% 11.9% 32.8% 23.3%
Research and Development
Expenditure
164.7 159.2 192.4 249.0 172.9
8.4% -3.3% 20.8% 29.4%
  FY2010 FY2011 FY2012 FY2013 FY2014
Total Assets 1,589.7 1,666.8 1,779.2 2,028.4 2,178.2
Net Assets 1,163.3 1,222.8 1,325.1 1,510.8 1,658.6
Equity Capital Ratio 72.4 72.5 73.7 73.2 74.7

From 1QFY2011, the method of translating revenue and expense accounts of foreign subsidiaries was changed from the spot rate as of the reporting date to the average exchange rate.The method of presentation for upfront licensing payments received was changed from non-operating income to net sales.Figures for FY2010 have been adjusted retrospectively to apply the changes above.

Geographical Segment Sales

  FY2014* (JPY billion) % of Net Sales
Japan 467.3 38.2
North America 545.3 44.5
Others 211.7 17.3
Sales to customers by market are shown.

Sales by Business Segment

  FY2014* (JPY billion) % of Net Sales
Pharmaceutical business 883.5 72.2
Nutraceutical business 232.7 19.0
Consumer products business 34.4 2.8
Other business 73.7 6.0
Sales to customers by market are shown.

Key Management Indicators

  FY2010 FY2011 FY2012 FY2013 FY2014
ROE (Return on equity: %) 7.9% 7.8% 9.7% 10.8% 9.2%
EPS (Earnings per share: yen) 164.5 165.2 221.9 278.1 264.2
Annual dividends per share (yen) 28.0 45.0 58.0 65.0 75.0
Payout ratio (%) 17.3% 27.2% 26.1% 23.4% 28.4%

Key Results (Graphs)Click to view tables.

  • Graph:Net Sales

  • Graph:Operating Income

  • Graph:Ordinary Income

  • Graph:Research and Development Expenditure

  • Graph:Geographical Segment Sales

  • Sales by Business Segment